The primary goal of this project is the development of an understanding of the mechanisms by which activation of opioid receptors regulates neuronal or endocrine cell function, and of the consequences at a molecular level of the effects of chronic opioid exposure. In the first set of proposed studies, emphasis will be given to interactions of opiate drugs with mu- type opioid receptors since most clinically used or abused opioids have selectivity for this opioid receptor class. Studies initiated in the current grant period utilizing the 7315c pituitary tumor cell, which carries a homogenous population of mu-class of opioid receptors, will be continued. A comparison will be made of the effects on mu-receptor function of morphine and other agents including full agonists (etorphine and Tyr-D-Ala-Gly-N(Me)Phe-Gly-ol) and partial agonists (buprenorphine, pentazocine). A more detailed study at a biochemical level of the effects of buprenorphine is required in view of the increasing interest in the use of this drug in the treatment of opiate drug addiction. The effects of chronic morphine exposure on the functional activity of G-proteins and on the turnover of opioid receptors will also be evaluated. A second part of the project will be concerned with the evaluation of possible k-type opioid receptor heterogeneity in neural tissues, and with the development of in vitro cell systems which can be used to examine the consequences of k-type receptor activation as NG 108-15 cells have been used to study delta- receptor function and 7315c cells to study mu-receptor function. The use of guinea pig cerebellar cells in primary cultures, and after fusion with neuroblastoma cells without opioid receptors, will be evaluated initially since guinea pig cerebellum has been shown to be very enriched in opioid receptors of the k-type. Other sources of k-receptor will be employed if use of guinea pig cerebellar cells becomes impracticable. In another set of studies, the acute and chronic effects of opioids on the release of norepinephrine and dopamine from defined neural pathways in rat and guinea pig will be examined. Both brain slices preparations will be studied. These studies are of significance since inhibition of neurotransmitter release appears to be an important mechanism underlying the effects of opioids on pain perception and mood.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA003102-09
Application #
3482665
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1982-09-30
Project End
1993-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20817
Gouty, S; Brown, J M; Rosenberger, J et al. (2010) MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons. Neuroscience 169:269-78
Di Benedetto, Manuela; Cavina, Chiara; D'Addario, Claudio et al. (2009) Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats. Neuropharmacology 56:761-7
Brown, Jeffrey M; Gouty, Shawn; Iyer, Varsha et al. (2006) Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. J Neurochem 98:495-505
Marti, Matteo; Mela, Flora; Fantin, Martina et al. (2005) Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci 25:9591-601
Buzas, Beata; Rosenberger, J; Kim, Kee-Won et al. (2002) Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture. Glia 39:237-46
Buzas, B; Symes, A J; Cox, B M (1999) Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. J Neurochem 72:1882-9
Azaryan, A V; Clock, B J; Rosenberger, J G et al. (1998) Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 76:278-83
Buzas, B; Rosenberger, J; Cox, B M (1998) Activity and cyclic AMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J Neurochem 71:556-63
Buzas, B; Rosenberger, J; Cox, B M (1998) Ca2+/calmodulin-dependent transcriptional activation of delta-opioid receptor gene expression induced by membrane depolarization in NG108-15 cells. J Neurochem 70:105-12
Buzas, B; Cox, B M (1997) Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 76:479-89

Showing the most recent 10 out of 20 publications